Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amino acids measurement
|
42 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 1 | 2016 | 2016 | |||||
Ankylosing spondylitis
|
422 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 1 | 2017 | 2017 | |||||
Aspartate aminotransferase measurement
|
108 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 1 | 2011 | 2011 | |||||
Blood basophil count (lab test)
|
429 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 1 | 2017 | 2017 | |||||
C-reactive protein measurement
|
245 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.800 | 3 | 2011 | 2017 | |||||
Calcification of coronary artery
|
3393 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.800 | 2 | 2012 | 2012 | |||||
Cholangitis, Sclerosing
|
284 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 1 | 2017 | 2017 | |||||
Cholecystolithiasis
|
58 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 1 | 2017 | 2017 | |||||
Cholelithiasis
|
65 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 1 | 2017 | 2017 | |||||
Chronic Kidney Diseases
|
120 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.800 | 2 | 2010 | 2012 | |||||
Creatinine measurement, serum (procedure)
|
140 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 2 | 2010 | 2016 | |||||
Crohn Disease
|
956 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 2 | 2017 | 2017 | |||||
Diabetes
|
349 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Diabetes Mellitus
|
440 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.030 | 1.000 | 3 | 2011 | 2016 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
1522 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.050 | 1.000 | 5 | 2008 | 2016 | ||||
Dyslipidemias
|
48 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.020 | 1.000 | 2 | 2008 | 2009 | ||||
Eosinophil count procedure
|
419 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 1 | 2017 | 2017 | |||||
Eosinophil count result
|
419 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 1 | 2017 | 2017 | |||||
Fasting blood glucose measurement
|
87 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 1 | 2013 | 2013 | |||||
FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5
|
2 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 4 | 2008 | 2010 | |||||
Fatty Liver
|
24 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Glomerular filtration rate finding
|
144 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.800 | 3 | 2013 | 2017 | |||||
Glucose measurement
|
89 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 1 | 2009 | 2009 | |||||
Glucose tolerance test
|
19 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.800 | 1 | 2010 | 2010 | |||||
Gout
|
90 | 0.667 | 0.321 | 2 | 27508073 | missense variant | T/C | snp | 0.63; 4.0E-06 | 0.67 | 0.700 | 2 | 2016 | 2017 |